These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25565812)

  • 81. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
    Tanghetti E; Kircik L; Wilson D; Dhawan S
    J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Benzoyl peroxide development, pharmacology, formulation and clinical uses in topical fixed-combinations.
    Harper JC
    J Drugs Dermatol; 2010 May; 9(5):482-7. PubMed ID: 20480791
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
    Kassem AA; Abd El-Alim SH; Asfour MH
    Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
    Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
    J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.
    Fakhouri T; Yentzer BA; Feldman SR
    J Drugs Dermatol; 2009 Jul; 8(7):657-61. PubMed ID: 19588642
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition.
    Jacob S; Nair AB; Al-Dhubiab BE
    J Liposome Res; 2017 Dec; 27(4):283-292. PubMed ID: 27558522
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
    Xu JH; Lu QJ; Huang JH; Hao F; Sun QN; Fang H; Gu J; Dong XQ; Zheng J; Luo D; Li FQ; Wang G; Gu H; Tian HQ; Yang HL; Xi LY; Li M; Zheng M; Wu Y; Tu YT; He YL; Zhao G; Sheng WX; Li J; Hamedani AG
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1176-82. PubMed ID: 27075705
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Formulation, In-Vitro and Ex-Vivo Evaluation of Tretinoin Loaded Cubosomal Gel for the Treatment of Acne.
    Sureka S; Gupta G; Agarwal M; Mishra A; K Singh S; P Singh R; Sah SK; de Jesus A Pinto T; Dua K
    Recent Pat Drug Deliv Formul; 2018; 12(2):121-129. PubMed ID: 29437029
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Combination of benzoyl peroxide 5% gel with liquid cleanser and moisturizer SPF 30 in acne treatment results in high levels of subject satisfaction, good adherence and favorable tolerability.
    Kim MR; Kerrouche N
    J Dermatolog Treat; 2018 Feb; 29(1):49-54. PubMed ID: 28678647
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Novel vesicular and particulate drug delivery systems for topical treatment of acne.
    Castro GA; Ferreira LA
    Expert Opin Drug Deliv; 2008 Jun; 5(6):665-79. PubMed ID: 18532922
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization.
    Tanghetti EA; Popp KF
    Dermatol Clin; 2009 Jan; 27(1):17-24. PubMed ID: 18984364
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
    Tanghetti E
    Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation.
    Kaur K; Jain S; Sapra B; Tiwary AK
    Curr Drug Deliv; 2007 Oct; 4(4):276-82. PubMed ID: 17979648
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris.
    Del Rosso JQ
    J Drugs Dermatol; 2007 Jun; 6(6):616-22. PubMed ID: 17668527
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
    Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
    J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
    Guerra-Tapia A
    J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy.
    Loesche C; Pernin C; Poncet M
    Eur J Dermatol; 2008; 18(5):524-6. PubMed ID: 18693154
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Luliconazole vesicular based gel formulations for its enhanced topical delivery.
    Kaur M; Singh K; Jain SK
    J Liposome Res; 2020 Dec; 30(4):388-406. PubMed ID: 31631734
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel.
    Harper JC
    J Drugs Dermatol; 2012 Dec; 11(12):1440-5. PubMed ID: 23377514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.